List of Excipients in API carbidopa and levodopa
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carbidopa and levodopa
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | ALUMINUM OXIDE | |
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | CELLULOSE, MICROCRYSTALLINE | |
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | CROSPOVIDONE | |
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | FD&C BLUE NO. 2 | |
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | HYDROXYPROPYL CELLULOSE | |
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | INDIGOTINDISULFONATE SODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing carbidopa and levodopa
Detailed excipient profiles for carbidopa and levodopa
Excipient focus: ALUMINUM OXIDE
carbidopa and levodopa drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| NCS HealthCare of KY Inc dba Vangard Labs | carbidopa and levodopa | 0615-8010 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing ALUMINUM OXIDE
Excipient focus: ASPARTAME
carbidopa and levodopa drug variants containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing ASPARTAME
Excipient focus: CALCIUM SILICATE
carbidopa and levodopa drug variants containing CALCIUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CALCIUM SILICATE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
carbidopa and levodopa drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
carbidopa and levodopa drug variants containing CELLULOSE, MICROCRYSTALLINE
carbidopa and levodopa drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
carbidopa and levodopa drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
carbidopa and levodopa drug variants containing CROSPOVIDONE
carbidopa and levodopa drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
carbidopa and levodopa drug variants containing D&C YELLOW NO. 10
carbidopa and levodopa drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
carbidopa and levodopa drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
carbidopa and levodopa drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: ETHYLCELLULOSES
carbidopa and levodopa drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing ETHYLCELLULOSES
Excipient focus: FD&C BLUE NO. 1
carbidopa and levodopa drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
carbidopa and levodopa drug variants containing FD&C BLUE NO. 2
carbidopa and levodopa drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
carbidopa and levodopa drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
carbidopa and levodopa drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
carbidopa and levodopa drug variants containing FD&C RED NO. 40
carbidopa and levodopa drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
carbidopa and levodopa drug variants containing FD&C YELLOW NO. 6
carbidopa and levodopa drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
carbidopa and levodopa drug variants containing FERRIC OXIDE RED
carbidopa and levodopa drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
carbidopa and levodopa drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | carbidopa and levodopa | 16729-079 |
| BluePoint Laboratories | carbidopa and levodopa | 68001-172 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYPROPYL CELLULOSE
carbidopa and levodopa drug variants containing HYDROXYPROPYL CELLULOSE
carbidopa and levodopa drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
carbidopa and levodopa drug variants containing HYPROMELLOSE
carbidopa and levodopa drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
carbidopa and levodopa drug variants containing HYPROMELLOSE 2208
carbidopa and levodopa drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
carbidopa and levodopa drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | carbidopa and levodopa | 16729-079 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| BluePoint Laboratories | carbidopa and levodopa | 68001-172 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
carbidopa and levodopa drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | carbidopa and levodopa | 0615-4569 |
| NCS HealthCare of KY LLC dba Vangard Labs | carbidopa and levodopa | 0615-8180 |
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 62756-461 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing HYPROMELLOSES
Excipient focus: INDIGOTINDISULFONATE SODIUM
carbidopa and levodopa drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: LACTOSE MONOHYDRATE
carbidopa and levodopa drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | carbidopa and levodopa | 16729-079 |
| BluePoint Laboratories | carbidopa and levodopa | 68001-172 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM PALMITOSTEARATE
carbidopa and levodopa drug variants containing MAGNESIUM PALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply | carbidopa and levodopa | 60429-650 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing MAGNESIUM PALMITOSTEARATE
Excipient focus: MAGNESIUM STEARATE
carbidopa and levodopa drug variants containing MAGNESIUM STEARATE
carbidopa and levodopa drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| Golden State Medical Supply | carbidopa and levodopa | 60429-650 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
carbidopa and levodopa drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing MANNITOL
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
carbidopa and levodopa drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
carbidopa and levodopa drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| Golden State Medical Supply | carbidopa and levodopa | 60429-650 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POVIDONE
carbidopa and levodopa drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing POVIDONE
Excipient focus: SILICON DIOXIDE
carbidopa and levodopa drug variants containing SILICON DIOXIDE
carbidopa and levodopa drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
carbidopa and levodopa drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
carbidopa and levodopa drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
carbidopa and levodopa drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
carbidopa and levodopa drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: SORBITOL
carbidopa and levodopa drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
carbidopa and levodopa drug variants containing STARCH, CORN
carbidopa and levodopa drug variants not containing STARCH, CORN
Excipient focus: TALC
carbidopa and levodopa drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing TALC
Excipient focus: TARTARIC ACID
carbidopa and levodopa drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing TARTARIC ACID
Excipient focus: TRIETHYL CITRATE
carbidopa and levodopa drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing TRIETHYL CITRATE
Excipient focus: WATER
carbidopa and levodopa drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
